(VEA) FTSE Developed Markets - Overview
Etf: Stocks, Equity, International, Diversified, Index
Dividends
| Dividend Yield | 3.42% |
| Yield on Cost 5y | 4.83% |
| Yield CAGR 5y | 5.64% |
| Payout Consistency | 93.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.0% |
| Relative Tail Risk | 2.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.82 |
| Alpha | 26.41 |
| Character TTM | |
|---|---|
| Beta | 0.677 |
| Beta Downside | 0.640 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.45% |
| CAGR/Max DD | 1.36 |
Description: VEA FTSE Developed Markets January 28, 2026
The Vanguard FTSE Developed Markets Index Fund ETF (NYSE ARCA: VEA) seeks to replicate the FTSE Developed All-Cap ex-U.S. Index by holding, in roughly the same weightings, the ~3,957 large-, mid- and small-cap stocks that compose the index across Canada, Europe and the Pacific region.
As of Q4 2025, VEA reports an expense ratio of 0.05 % and total assets under management of roughly $115 billion. The fund’s 12-month total return (including dividends) was +4.2 %, lagging the index by 0.1 % after fees-a modest tracking error that aligns with Vanguard’s historical performance. Sector allocations are dominated by Financials (≈20 % of assets), Consumer Discretionary (≈15 %), and Health Care (≈13 %). Geographic exposure remains heavily weighted to Europe (≈55 % of NAV), with Canada at ≈15 % and the Pacific region (including Japan and Australia) at ≈30 %. Current drivers of performance include the European Central Bank’s gradual tightening cycle, which pressures Euro-zone equity valuations, and resilient demand for Canadian natural-resource exporters amid higher commodity prices. The Pacific markets are benefiting from a rebound in technology spending, though the sector’s contribution is tempered by valuation concerns.
If you’re looking to deepen the quantitative analysis of VEA’s risk-adjusted metrics, a quick check on ValueRay can surface the latest factor exposures and scenario-based stress tests.
What is the price of VEA shares?
Over the past week, the price has changed by +1.77%, over one month by +5.04%, over three months by +13.39% and over the past year by +37.75%.
Is VEA a buy, sell or hold?
What are the forecasts/targets for the VEA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 81.3 | 20.6% |
VEA Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 205.18b USD (205.18b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 205.18b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 205.18b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.41% (E(205.18b)/V(205.18b) * Re(8.41%) + (debt-free company))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)